Related Experiment Videos
Stable human lymphoblastoid cell lines constitutively expressing hepatitis C virus proteins
Benno Wölk1, Christel Gremion2, Natalia Ivashkina1
1Department of Medicine II, University of Freiburg, Hugstetter Str. 55, D-79106 Freiburg, Germany.
The Journal of General Virology
|May 26, 2005
Summary
Researchers developed novel cell lines to study hepatitis C virus (HCV) immune responses. These cell lines enable better understanding of cellular immunity and evaluation of new HCV vaccines and therapies.
Area of Science:
- Immunology
- Virology
- Hepatology
Background:
- Cellular immunity is crucial for clearing hepatitis C virus (HCV) and disease progression.
- Studying HCV-specific immune responses is challenging due to limitations in current cell-culture systems.
Purpose of the Study:
- To establish and characterize novel human B-lymphoblastoid x T hybrid cell lines expressing HCV proteins.
- To assess the utility of these cell lines for studying cellular immune responses to HCV.
Main Methods:
- Development of stable B-lymphoblastoid x T hybrid cell lines (T1/NS3-4A and T1/HCVcon) expressing HCV NS3-4A complex or the full HCV polyprotein.
- Maintenance of cell lines in continuous culture for over a year with stable characteristics.
- Assessment of viral protein processing and presentation via MHC class I pathway using HCV-specific cytotoxic T lymphocytes.
Main Results:
- The established cell lines demonstrated stable characteristics and accurate processing of HCV proteins.
- Viral proteins were localized in the cytoplasm (dot-like structures or perinuclear fringe).
- HCV-specific cytotoxic T lymphocytes efficiently lysed the engineered cell lines, confirming endogenous viral protein processing and MHC class I presentation.
Conclusions:
- The novel T1/NS3-4A and T1/HCVcon cell lines are valuable tools for investigating HCV-specific cellular immune responses.
- These cell lines can be used to evaluate novel vaccine and immunotherapeutic strategies against HCV.